Insulet Appoints Mike Panos as Chief Commercial Officer

Core Insights - Insulet Corporation has appointed Mike Panos as Executive Vice President and Chief Commercial Officer, effective immediately, to lead its global commercial organization [1][2][3] Group 1: Leadership Appointment - Mike Panos brings 30 years of commercial leadership experience in the medical technology sector, previously serving at Stryker Corporation in various senior roles [2][3] - His expertise includes building high-performing sales organizations and driving sustained double-digit growth in competitive markets [2][3] Group 2: Strategic Vision - Insulet's President and CEO, Ashley McEvoy, emphasized the significant growth opportunity driven by strong clinical outcomes and customer-centric innovation in automated insulin delivery for diabetes management [2][4] - The company aims to strengthen its capabilities and structure to capture growth opportunities, including expanding into new patient populations and care settings [3][4] Group 3: Product and Market Focus - Insulet's Omnipod product platform offers a unique alternative to traditional insulin delivery methods, providing up to three days of non-stop insulin delivery without the need for needles [5][6] - The company is focused on expanding global adoption of its automated insulin delivery technology, particularly among those not yet benefiting from it [4][5]